Does Braftovi Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- ENCORAFENIB; IVOSIDENIB/ATAZANAVIR
- SELECTED STRONG CYP3A4 INDUCERS/NISOLDIPINE
- STRONG CYP3A4 INDUCERS/LENACAPAVIR
- SELECTED IMMUNOSUPPRESSANTS/NADOFARAGENE FIRADENOVEC
- STRONG CYP3A4 INDUCERS/MAVACAMTEN
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/PACRITINIB
- SLT STRONG CYP3A4 INDUCERS THAT PROLONG QT/LEVOKETOCONAZOLE
- STRONG CYP3A4 INDUCERS PROLONG QT/ARTEMETHER; LUMEFANTRINE
- CYP3A4 & UGT1A1 INDUCERS/CABOTEGRAVIR-RILPIVIRINE
- STRONG AND MODERATE CYP3A4 INDUCERS/LONAFARNIB
- STRONG CYP3A4 INDUCERS/FOSTEMSAVIR
- STRONG CYP3A4 INDUCERS/TAMOXIFEN
- STRONG CYP3A4 INDUCERS/LORLATINIB
- CYP3A4 INDUCERS/DORAVIRINE
- STRONG OATP1B1 INHIBITORS/ELAGOLIX
- STRONG CYP3A4 INDUCERS/ELBASVIR-GRAZOPREVIR
- SELECTED IMMUNOSUPPRESSANTS/TALIMOGENE LAHERPAREPVEC
- STRONG CYP3A4 INDUCERS/DELAMANID
- SLT MODERATE-STRONG CYP3A4 INDUCERS/SLT HEPATITIS C AGENTS
- STRONG CYP3A4 INDUCERS/DACLATASVIR
- SELECT CYP3A4 INDUCERS/RILPIVIRINE
- CYP3A4 INDUCERS/SELECTED PROTEASE INHIBITORS; COBICISTAT
- STRONG CYP3A4 INDUCERS/TICAGRELOR; VORAPAXAR
- STRONG CYP3A4 INDUCERS/LURASIDONE
- SELECTED STRONG CYP3A4 INDUCERS/PRAZIQUANTEL
- SELECTED CYP3A4 INDUCERS/NIFEDIPINE
- STRONG CYP3A4 INDUCERS/RANOLAZINE
- SELECTED STRONG CYP3A4 INDUCERS/NIMODIPINE
- SELECTED IMMUNOSUPPRESSIVE AGENTS/LIVE VACCINES; LIVE BCG
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/EFALIZUMAB; NATALIZUMAB
- SELECTED CYP3A4 INDUCERS/ISAVUCONAZONIUM; VORICONAZOLE
- SELECTED STRONG CYP3A4 INDUCERS/DELAVIRDINE; ETRAVIRINE
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- ENCORAFENIB/STRONG AND MODERATE CYP3A4 INHIBITORS
- ENCORAFENIB/STRONG CYP3A4 INDUCERS
- ENCORAFENIB/QT PROLONGING AGENTS
- ENCORAFENIB/IVOSIDENIB
- ENCORAFENIB/STRONG & MODERATE 3A4 INHIB THAT PROLONG QT
- ENCORAFENIB/CYP3A4 INHIBITORS AND SUBSTRATES
- ENCORAFENIB/CYP3A4 INHIBITORS AND SUBSTRATES THAT PROLONG QT
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/VEMURAFENIB
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/TOREMIFENE
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/TACROLIMUS
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/OSIMERTINIB
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/MIDOSTAURIN
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/MACIMORELIN
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/IVABRADINE
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/SELECT ANTIMALARIALS
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/AMIODARONE
- SELECTED STRONG CYP3A4 INDUCERS/SELECTED IMMUNOSUPPRESSANTS
- STRONG CYP3A4 INDUCERS AND SUBSTRATES/ENZALUTAMIDE
- IMMUNOSUPPRESSIVE STRONG CYP3A4 INDUCERS/UPADACITINIB
- IMMUNOSUPPRESSIVE STRONG CYP3A4 INDUCERS/RITLECITINIB
- ENCORAFENIB/UBROGEPANT
- STRONG AND MODERATE CYP3A4 INDUCERS/LEMBOREXANT
- STRONG AND MODERATE CYP3A4 INDUCERS/NIROGACESTAT
- STRONG OR MODERATE CYP3A4 INDUCERS/REPOTRECTINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/CAPIVASERTIB
- IMMUNOSUPPRESSIVE MODER AND STRONG CYP3A4 INDUCERS/SIPONIMOD
- SELECTED STRONG CYP3A4 INDUCERS/NEVIRAPINE
- STRONG CYP3A4 INDUCERS/FRUQUINTINIB
- IMMUNOSUPPRESSIV; IMMUNOMODULATORS THAT PROLONG QT/ETRASIMOD
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/GEPIRONE
- ENCORAFENIB/PAZOPANIB
- CYP3A4 INDUCERS/ZURANOLONE
- STRONG & MODERATE CYP3A4 INDUCER THAT PROLONG QT/QUIZARTINIB
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/PANOBINOSTAT
- STRONG CYP3A4 INDUCERS/VINCRISTINE
- STRONG CYP3A4 INDUCERS/PACLITAXEL
- STRONG CYP3A4 INDUCERS/DOXORUBICIN
- STRONG CYP3A4 INDUCERS/DOCETAXEL
- STRONG CYP3A4 INDUCERS/CABAZITAXEL
- STRONG & MODERATE CYP3A4 INDUCERS/SONIDEGIB
- STRONG & MODERATE CYP3A4 INDUCERS/PALBOCICLIB
- STRONG & MODERATE CYP3A4 INDUCERS/OLAPARIB
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/SUNITINIB
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/SORAFENIB
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/DASATINIB
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/VANDETANIB
- STRONG CYP3A4 INDUCERS/IBRUTINIB
- STRONG CYP3A4 INDUCERS/GEFITINIB
- CYP3A4 INDUCERS/ERLOTINIB
- STRONG CYP3A4 INDUCERS/CABOZANTINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/PALOVAROTENE
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/LAPATINIB
- STRONG & MODERATE CYP3A4 INDUCERS/AXITINIB
- STRONG CYP3A4 INDUCERS/TRETINOIN
- STRONG AND MODERATE CYP3A4 INDUCERS/LENIOLISIB
- OATP1B3 INHIBITORS/ZAVEGEPANT
- STRONG AND MODERATE CYP3A4 INDUCERS/OMAVELOXOLONE
- STRONG CYP3A4 INDUCERS/SPARSENTAN
- STRONG AND MODERATE CYP3A4 INDUCERS/ELACESTRANT
- STRONG CYP3A4 INDUCERS/PIRTOBRUTINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/CARIPRAZINE
- STRONG AND MODERATE CYP3A4 INDUCERS/OLUTASIDENIB
- STRONG CYP3A4 INDUCERS/THIOTEPA
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/SAVOLITINIB
- STRONG OR MODERATE CYP3A4 INDUCERS/VONOPRAZAN
- STRONG CYP3A4 INDUCERS/ALPELISIB
- STRONG OR MODERATE CYP3A4 INDUCERS/GANAXOLONE
- STRONG CYP3A4 INDUCERS/MITAPIVAT
- STRONG CYP3A4 INDUCERS/CYCLOPHOSPHAMIDE
- STRONG CYP3A4 INDUCERS/RIVOCERANIB
- STRONG CYP3A4 INDUCERS/TADALAFIL (BPH, PAH)
- SELECTED STRONG CYP3A4 INDUCERS/MARIBAVIR
- STRONG CYP3A4 INDUCERS/SURUFATINIB
- STRONG OR MODERATE CYP3A4 INDUCERS/AVACOPAN
- ENCORAFENIB; RIFAMPIN/ATOGEPANT
- STRONG OR MODERATE 3A4 INDUCERS THAT PROLONG QT/MOBOCERTINIB
- SELECTED INHIBITORS OF BCRP WITH MYELOSUPPRESSION/CLADRIBINE
- IMMUNOSUPPRESSIVES;IMMUNOMODULATORS THAT PROLONG QT/OZANIMOD
- IMMUNOSUPPRES;IMMUNOMODULATORS THAT PROLONG QT/FINGOLIMOD
- IMMUNOSUPPRESSIV;IMMUNOMODULATORS THAT PROLONG QT/PONESIMOD
- STRONG & MODERATE 3A4 INDUCERS THAT PROLONG QT/FEXINIDAZOLE
- STRONG AND MODERATE CYP3A4 INDUCERS/FINERENONE
- MYELOSUPPRESSIVES; IMMUNOMODULATORS/SODIUM IODIDE I 131
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/FILGOTINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/IBREXAFUNGERP
- OATP1B1-3 INHIBITORS/BRINCIDOFOVIR
- STRONG CYP3A4 INDUCERS/SAMIDORPHAN
- STRONG AND MODERATE CYP3A4 INDUCERS/INFIGRATINIB
- STRONG CYP3A4 INDUCERS/SOTORASIB
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/ROMIDEPSIN
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/HALOPERIDOL
- STRONG AND MOD CYP3A4 INDUCERS THAT PROLONG QT/PIMAVANSERIN
- STRONG & MOD CYP3A4 INDUCERS THAT PROLONG QT/BEDAQUILINE
- STRONG AND MOD CYP3A4 INDUCERS THAT PROLONG QT/SELPERCATINIB
- STRONG OR MODERATE CYP3A4 INDUCERS THAT PROLONG QT/LEFAMULIN
- STRONG AND MOD CYP3A4 INDUCERS THAT PROLONG QT/ENTRECTINIB
- STRONG AND MOD CYP3A4 INDUCERS THAT PROLONG QT/GLASDEGIB
- SELECTED IMMUNOSUPPRESSANTS/LEFLUNOMIDE; TERIFLUNOMIDE
- STRONG AND MODERATE CYP3A4 INDUCERS/VOCLOSPORIN
- STRONG CYP3A4 INDUCERS AND SUBSTRATES/LUMACAFTOR-IVACAFTOR
- STRONG CYP3A4 INDUCERS/PRALSETINIB
- STRONG CYP3A4 INDUCERS/PLITIDEPSIN
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/BARICITINIB
- STRONG CYP1A2, CYP2B6 OR CYP3A4 INDUCERS/FENFLURAMINE
- STRONG CYP3A4 INDUCERS/LURBINECTEDIN
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/INEBILIZUMAB
- STRONG CYP3A4 INDUCERS/RIPRETINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/CAPMATINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/PEMIGATINIB
- STRONG AND MODERATE CYP3A4 INDUCERS/SELUMETINIB
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/LEVOMETHADYL
- STRONG AND MODERATE CYP3A4 INDUCERS/RIMEGEPANT
- STRONG OR MODERATE CYP3A4 INDUCERS/TAZEMETOSTAT
- MYELOSUPPRESSIVE AGENTS THAT PROLONG QT/CLOZAPINE
- STRONG CYP3A4 INDUCERS/REGORAFENIB
- STRONG OR MODERATE CYP3A4 INDUCERS/AVAPRITINIB
- CYP3A4 INDUCERS/LUMATEPERONE
- STRONG OR MODERATE CYP3A4 INDUCERS/DARIDOREXANT
- STRONG CYP3A4 INDUCERS/ZANUBRUTINIB
- SELECTED STRONG CYP3A4 INDUCERS/ISTRADEFYLLINE
- STRONG AND MODERATE CYP3A4 INDUCERS/PRETOMANID
- STRONG CYP3A4 INDUCERS/PEXIDARTINIB
- SELECTED STRONG CYP3A4 INDUCERS; RIFABUTIN/BICTEGRAVIR
- STRONG CYP3A4 INDUCERS/TIVOZANIB
- STRONG CYP3A4 INDUCERS/ERDAFITINIB
- STRONG CYP3A4 INDUCERS; RIFABUTIN/LAROTRECTINIB
- STRONG CYP3A4 INDUCERS/ERAVACYCLINE
- STRONG CYP3A4 INDUCER/SLT LONG-ACTING ARIPIPRAZOLE INJECTION
- ENCORAFENIB/HORMONAL CONTRACEPTIVE AGENTS
- STRONG CYP3A4 INDUCERS/FOSTAMATINIB
- STRONG CYP3A4 INDUCERS/ACALABRUTINIB
- STRONG CYP3A4 INDUCERS/ABEMACICLIB
- STRONG CYP3A4 INDUCERS/COPANLISIB
- SELECTED OATP INHIBITORS/VOXILAPREVIR
- STRONG AND MODERATE CYP3A4 INDUCERS/NERATINIB
- STRONG CYP3A4 INDUCERS; RIFABUTIN/BRIGATINIB
- STRONG CYP3A4 INDUCERS/VALBENAZINE
- STRONG CYP3A4 INDUCERS/NALDEMEDINE
- STRONG CYP3A4 INDUCERS/VENETOCLAX
- STRONG CYP3A4 INDUCERS/TOFACITINIB
- SLT MODERATE AND STRONG CYP3A4 INDUCERS/IXAZOMIB
- STRONG CYP3A4 INDUCERS/TRABECTEDIN
- STRONG CYP3A4 INDUCERS/FLIBANSERIN
- IMMUNOSUPPRES;IMMUNOMODUL/SELECTED MULTIPLE SCLEROSIS AGENTS
- OATP1B1 INHIBITORS/ELUXADOLINE
- STRONG CYP3A4 INDUCERS/ABIRATERONE
- STRONG CYP3A4 INDUCERS/NALOXEGOL
- STRONG CYP3A4 INDUCERS/ELIGLUSTAT
- STRONG CYP3A4 INDUCERS/RAMELTEON; SUVOREXANT; TASIMELTEON
- STRONG & MODERATE CYP3A4 INDUCERS/GUANFACINE
- STRONG OR MODERATE CYP3A4 INDUCERS/SIMEPREVIR
- SELECTED UGT1A & CYP3A4 INDUCERS/DOLUTEGRAVIR
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/TOFACITINIB
- STRONG CYP3A4 INDUCERS; RIFABUTIN/PONATINIB
- SELECTED CYP3A4 INDUCERS/COBICISTAT-ELVITEGRAVIR
- SELECTED STRONG CYP3A4 INDUCERS/BORTEZOMIB
- STRONG CYP3A4 INDUCERS/IVACAFTOR
- STRONG & MODERATE CYP3A4 INDUCERS/COBIMETINIB
- SELECTED MYELOSUPPRESSIVE AGENTS/DEFERIPRONE
- STRONG P-GP OR CYP3A4 INDUCER/LINAGLIPTIN
- STRONG CYP3A4 INDUCERS/APREMILAST; ROFLUMILAST
- SELECTED STRONG CYP3A4 INDUCERS/IXABEPILONE
- SELECTED STRONG CYP3A4 INDUCERS/ULIPRISTAL
- STRONG CYP3A4 INDUCERS/TOLVAPTAN
- STRONG CYP3A4 INDUCERS/MARAVIROC
- STRONG CYP3A4 INDUCERS/MACITENTAN
- SELECTED STRONG CYP3A4 INDUCERS/IRINOTECAN
- STRONG CYP3A4 INDUCERS/BOSUTINIB
- SELECTED QT PROLONGING AGENTS/ZIPRASIDONE
- POSSIBLE QT PROLONGING AGENTS/SERTINDOLE
- STRONG CYP3A4 INDUCERS/EXEMESTANE
- STRONG CYP3A4 INDUCERS/ROLAPITANT
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- ENCORAFENIB/POSSIBLE QT PROLONGING AGENTS
- STRONG CYP3A4 INDUCERS/RISPERIDONE INTRAMUSCULAR MONTHLY
- STRONG CYP3A4 INDUC THAT PROLONG QT/PALIPERIDONE;QUETIAPINE
- POSSIBLE QT PROLONGING AGENTS/DEXMEDETOMIDINE SUBLINGUAL
- STRONG CYP3A4 INDUCERS/BELUMOSUDIL (400 MG)
- OATP1B1-3 INHIBITORS/MOMELOTINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/TOCILIZUMAB
- STRONG AND MODERATE CYP3A4 INDUCERS/SILDENAFIL (PAH)
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/UBLITUXIMAB
- QT PROLONGING AGENTS/TUCIDINOSTAT
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/SARILUMAB
- QT PROLONGING AGENTS/TRICLABENDAZOLE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/COVID-19 VACCINES
- STRONG CYP3A4 INDUCERS/BELUMOSUDIL
- STRONG CYP3A4 INDUCERS THAT PROLONG QT/PITOLISANT
- QT PROLONGING AGENTS/GALANTAMINE
- POSSIBLE QT PROLONGING AGENTS/LEVOMEPROMAZINE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/USTEKINUMAB
- POSSIBLE QT PROLONGING AGENTS/OXALIPLATIN
- QT PROLONGING AGENTS/OSILODROSTAT
- QT PROLONGING AGENTS/AMISULPRIDE
- STRONG CYP3A4 INDUCERS/CANNABIDIOL; TETRAHYDROCANNABINOL
- SELECTED UGT AND STRONG CYP3A4 INDUCERS/OXCARBAZEPINE
- POSSIBLE QT PROLONGING AGENTS/TRAZODONE (< 100 MG)
- STRONG AND MODERATE CYP3A4 INDUCERS/PERAMPANEL
- POSSIBLE QT PROLONGING AGENTS/TRAZODONE (>= 100 MG)
- STRONG CYP3A4 INDUCERS/VILAZODONE
- POSSIBLE QT PROLONGING AGENTS/GADOFOSVESET
- SELECTED CYP3A4 INDUCERS/SELECTED BENZODIAZEPINES
- STRONG CYP3A4 INDUCERS/SELECT SEDATIVE HYPNOTICS; BUSPIRONE
- SELECTED STRONG CYP3A4 INDUCERS/SELECTED OPIOIDS
- CYP3A4 INDUCERS/DOXYCYCLINE
- SELECTED CYP3A4 INDUCERS/CORTICOSTEROIDS
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.